An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

NCT02907619 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
59
Enrollment
INDUSTRY
Sponsor class

Stopped Termination Date: 30Aug2018; Reason for termination: Lack of Efficacy

Conditions

Interventions

Sponsor

Pfizer